Dacryoadenitis is an uncommon disease process, and thus communication between health care providers can facilitate appropriate diagnosis and treatment of patients with the disease. An oculoplastic surgeon may be needed to perform a lacrimal gland biopsy to aid in diagnosis. In cases of inflammatory dacryoadenitis that recur after completion of a steroid taper, collaboration with a rheumatologist to consider initiation of immunomodulatory therapy is frequently beneficial. Similarly, coordination with rheumatology and internal medicine is advisable when patients with dacryoadenitis report extraocular symptoms that may indicate a systemic disease process. (Level V) an interprofessional team approach involving plastic specialty certified nurses and specialist physicians providing evaluation and follow up will result in the best outcomes. [Level V]